Gossamer Bio, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ABOS
|
Acumen Pharmaceuticals, Inc. | $2.24 | $157.41 M | -2.5 | 51 | $0 |
 AKRO
|
Akero Therapeutics, Inc. | $29.55 | $1.59 B | -7.1 | 60 | $0 |
 ALEC
|
Alector, Inc. | $3.77 | $420.24 M | -3.14 | 241 | $97.06 M |
 AMLX
|
Amylyx Pharmaceuticals, Inc. | $5.30 | $120.37 M | -1.65 | 384 | $380.79 M |
 BCEL
|
Atreca, Inc. | $0.09 | $3.66 M | -0.04 | 90 | $770,000 |
 BDTX
|
Black Diamond Therapeutics, Inc. | $2.51 | $291.95 M | -3.13 | 54 | $0 |
 BMEA
|
Biomea Fusion, Inc. | $6.43 | $148.81 M | -1.17 | 107 | $0 |
 FDMT
|
4D Molecular Therapeutics, Inc. | $8.31 | $1.17 B | -9.63 | 147 | $20.72 M |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 HARP
|
Harpoon Therapeutics, Inc. | $23.01 | $865.08 M | -15.04 | 45 | $31.92 M |
 INZY
|
Inozyme Pharma, Inc. | $2.88 | $286.39 M | -3.43 | 59 | $0 |
 KRON
|
Kronos Bio, Inc. | $0.85 | $44.62 M | -0.37 | 58 | $6.29 M |
 LYRA
|
Lyra Therapeutics, Inc. | $0.16 | $19.53 M | -0.27 | 88 | $1.56 M |
 NVCT
|
Nuvectis Pharma, Inc. | $5.04 | $116.38 M | -4.5 | 13 | $0 |
 PASG
|
Passage Bio, Inc. | $0.48 | $73.04 M | -0.77 | 58 | $0 |
 REPL
|
Replimune Group, Inc. | $10.79 | $485.18 M | -2.44 | 331 | $0 |
 STOK
|
Stoke Therapeutics, Inc. | $11.89 | $774.50 M | -6.14 | 110 | $8.78 M |
 TCRR
|
TCR2 Therapeutics Inc. | $1.48 | $58.11 M | -0.35 | 58 | $0 |
 TERN
|
Terns Pharmaceuticals, Inc. | $5.69 | $462.44 M | -5.67 | 66 | $0 |
 XFOR
|
X4 Pharmaceuticals, Inc. | $0.38 | $169.62 M | -1.51 | 127 | $0 |